EP Patent

EP1601661A2 — Compositions and methods for preventing and treating endotoxin-related diseases and conditions

Assigned to Eisai Co Ltd · Expires 2005-12-07 · 20y expired

What this patent protects

The invention provides pharmaceutical compositions for preventing and treating endotoxin-related diseases and conditions, as well as methods for making and using such compositions.

USPTO Abstract

The invention provides pharmaceutical compositions for preventing and treating endotoxin-related diseases and conditions, as well as methods for making and using such compositions.

Drugs covered by this patent

minocycline-hydrochloride (MINOCYCLINE HYDROCHLORIDE)

Patent Metadata

Patent number: EP1601661A2
Jurisdiction: EP
Classification: —
Expires: 2005-12-07
Drug substance claim: No
Drug product claim: No
Assignee: Eisai Co Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.